Artificial intelligence will involve more patients in breast cancer trials
Rochester, Minnesota -- Mayo Clinic and IBM Watson Health today announced the results of early clinical trial matching using the Watson system (a cognitive computing system from IBM). The use of this system in the Mayo Clinic's oncology services is associated with an increase in patients participating in the Mayo breast cancer clinical trial.
Both of these have also announced an agreement to expand and expand the training and use of the system. Training on other cancer type trials is also underway. Currently, the system has been able to support clinical trials matching breast, lung and gastrointestinal cancer.
Clinical trials can provide patients with promising new treatments. But getting the patient to participate and being matched to the appropriate trial is a time consuming and labor intensive process. Only 5% of cancer patients in the United States participate in clinical trials. Because of the small number of participants, many clinical trials are extremely slow or impossible to complete. This not only lags behind the progress of the study, but also delays the patient's access to better treatment and improved patient care.
Tufia Haddad, MD, an oncologist at the Mayo Clinic and a leader in the Watson Clinical Trials Matching Program, said: "The new solutions can help address these clinical needs and promote cancer research and treatment to improve patient health."
Dr. Haddad will present the project at the annual meeting and exhibition of the Healthcare Information and Management Systems Association in Las Vegas.
The goal of the Watson Clinical Trial Matching Program is to accurately and consistently match eligible patients to clinical trials so that healthcare providers and patients can consider appropriate trials as part of their health care plan. Over time, Mayo's team of experts identified the best workflow and screening process and began educating patients on clinical trials. In July 2016, Mayo implemented the system for ambulatory breast cancer patients through her Clinical Screening Research Coordinator.
Within 11 months of the start of the implementation, Mayo's participation in clinical trials for breast cancer systemic therapy increased by an average of 80%. Compared with traditional manual methods, the time to screen individual patients for clinical trial matching has also decreased.
Dr. Haddad said: “This allows all patients to have the opportunity to participate in screening for clinical trials. The speed and accuracy of the Watson System and Screening Coordinator team enables our physicians to effectively develop medical care for patients that reflect these patients. Treatment plans for various possible options for nursing."
Mayo Clinic and IBM Watson Health plan will continue to develop the system to include trials of other types of cancer as well as other related aspects such as surgery, radiation therapy and supportive care.
Wireless Bluetooth Keyboard,Best Wireless Gaming Keyboard,Bluetooth Keyboard,Keyboard Bluetooth Dual-Mode Connection
Guangzhou Lufeng Electronic Technology Co. , Ltd. , https://www.lufengelectronics.com